| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Abeona Therapeutics Inc.
13D
ABEO · 00289Y206
|
6.1% |
10/23/2026
Event 10/15/2026
|
||||
| James Russell Revocable Trust | 6.1% | |||||
| James Russell | 6.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.